The Fellow on Call
The Fellow on Call
Advertisement
The Fellow on CallThe Fellow on Call | October 26, 2023
In this episode of "The Fellow on Call," the hosts discuss approaches to primary refractory diffuse large B-cell lymphoma.
Listen Now
The Fellow on CallThe Fellow on Call | October 20, 2023
In this episode of "The Fellow on Call," the hosts discuss relapsed DLBCL, CAR-T versus autologous transplant, and more.
The Fellow on CallThe Fellow on Call | October 20, 2023
In this episode of "The Fellow on Call," the hosts focus on primary refractory DLBCL, CAR-T therapy, and more.
The Fellow on CallThe Fellow on Call | October 10, 2023
In this episode of "The Fellow on Call," the hosts focus on CAR-T, bispecific antibodies, and more.
The Fellow on CallThe Fellow on Call | October 15, 2023
In the third episode of the DLBCL series, the hosts discuss how to manage DLBCL in the advanced stages of the disease.
The Fellow on CallThe Fellow on Call | October 12, 2023
In this episode of "The Fellow on Call," the DLBCL series continues with a focus on treatment and management strategies.
Advertisement
The Fellow on CallThe Fellow on Call | October 2, 2023
In this episode of "The Fellow on Call," the hosts kick off a new series focusing on DLBCL.
The Fellow on CallThe Fellow on Call | August 1, 2023
The hosts discuss how classical Hodgkin's lymphoma is currently treated and the implications of data from SWOG 1826.
The Fellow on CallThe Fellow on Call | August 15, 2023
Dr. Manni Mohyuddin discusses multiple myeloma treatment as an art where clinicians take imperfect data to treat patients.
The Fellow on CallThe Fellow on Call | March 15, 2023
The ins and outs of molecular testing with The Fellow on Call.
The Fellow on CallThe Fellow on Call | March 15, 2023
In this podcast episode of The Fellow on Call, they discuss the application of flow cytometry in hematologic malignancies.
The Fellow on CallThe Fellow on Call | August 1, 2023
Why do we use lenalidomide maintenance therapy post-stem cell transplant?
The Fellow on CallThe Fellow on Call | August 1, 2023
The Fellow On Call break down immunochemistry in hematologic pathology.
The Fellow on CallThe Fellow on Call | August 1, 2023
Part two of the Heme Path Series is a debate on two cytogenetic methodologies: FISH and conventional karotype.
The Fellow on CallThe Fellow on Call | June 21, 2023
The Fellow on Call discuss MGUS and smoldering myeloma.
The Fellow on CallThe Fellow on Call | August 1, 2023
The Fellow on Call recount key trials in autologous transplant in multiple myeloma.
The Fellow on CallThe Fellow on Call | August 1, 2023
A discussion on transplant in myeloma and real-life decision-making.
The Fellow on CallThe Fellow on Call | August 1, 2023
In part six of the Myeloma Series, a historical perspective on the treatment evolution of myeloma.
The Fellow on CallThe Fellow on Call | August 1, 2023
The Fellow on Call discuss APL, a true hematologic emergency.
The Fellow on CallThe Fellow on Call | August 1, 2023
The Fellow on Call discuss plasma cell dyscrasias and MGUS.
Advertisement
Advertisement
Editorial Board